Want to join the conversation?
Pharmaceutical company $MYL said that in Dec. 2015 it submitted its ANDA for fluticasone propionate 100, 250, 500 mcg and salmeterol 50 mcg inhalation powder to the US FDA. This product is the generic version of Advair Diskus indicated for treatment of asthma and reducing aggravation in patients with chronic obstructive pulmonary disease.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.